ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 53 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01ES027901
National Institutes of Health
Grant: R01CA232587
National Institutes of Health
Grant: R01ES033197
National Institutes of Health
Grant: R01CA263506
National Institutes of Health
Grant: K02ES029119
National Institutes of Health
Grant: NEC-129306
National Institutes of Health
Grant: SAP#41000
NIEHS NIH HHS
Grant: R01ES024151
National Institutes of Health
Grant: 5R01ES027901-03
Chromium in carcinogenesis and angiogenesis
National Institutes of Health
Grant: 1R01ES033197-01A1
METTL3 in chromium-induced angiogenesis and carcinogenesis
National Institutes of Health
Grant: 7K02ES029119-04
New Mechanism of Arsenic Carcinogenesis
National Institutes of Health
Grant: 1R01CA263506-01A1
MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response
National Institutes of Health
Grant: 5R01CA232587-05
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments
FWCI
3.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals